DA Davidson lowered the firm’s price target on Clorox (CLX) to $169 from $171 and keeps a Neutral rating on the shares. The company reported a ...

Barclays analyst Lauren Lieberman raised the firm’s price target on Clorox (CLX) to $140 from $130 and keeps an Underweight rating on the ...

Barclays (LON:BARC) analyst Lauren Lieberman maintained an Underweight rating on Clorox stock (NYSE:CLX), with a price target of $130.00. According to InvestingPro data, the stock is currently trading ...

Caprock Group LLC increased its position in The Clorox Company (NYSE:CLX – Free Report) by 10.7% during the fourth quarter, ...

Clorox Co (CLX), with a market capitalization of $19.8 billion, reported its second-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $1.55, compared to the ...

Clorox management is confident in its Q4 forecast expecting mid- to high-single-digit growth in organic sales driven by ERP ...

Barclays analyst Lauren Lieberman maintained an Underweight rating and cut the price target from $139 to $130 on Jan. 17, ...

Geneos Wealth Management Inc. lessened its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 8.3% during ...

Clorox divested its Better Health Vitamins, Minerals and Supplements VMS business. This highlights an important step in the evolution of its portfolio, supporting CLX’s target to lower ...